Latest Biotech News

Cutting-edge genomic studies from the Wellcome Sanger Institute, University of Cambridge, and Cambridge University Hospitals reveal distinct mutational signatures caused by various chemotherapy...

Beckley Psytech and Atai Life Sciences have reported promising results from mid-stage clinical trials of psychedelic-based treatments targeting treatment-resistant depression. Beckley's intranasal...

The biotech sector is seeing rapid innovation at the intersection of artificial intelligence (AI) and genomics. Advances include AI-powered molecular diagnostics, computational drug discovery, and...

Beckley Psytech has reported positive Phase 2b clinical trial results for its intranasal psychedelic compound BPL-003 in patients with treatment-resistant depression. The trial demonstrated...

AbbVie announced a $2.1 billion acquisition of Capstan Therapeutics, gaining rights to a phase 1-stage in vivo CAR-T therapy targeting CD19 and Capstan’s proprietary targeted lipid nanoparticle...

Moderna reported positive Phase 3 data for its seasonal influenza vaccine mRNA-1010, demonstrating a 26.6% relative efficacy over a standard-dose comparator in adults 50 years and older across...

Recent studies have uncovered key mechanisms impacting various cancers and neurodegenerative diseases. Groundbreaking research highlights the role of mutant p53 and SH3BGRL in cancer cell...

Innovations in artificial intelligence are reshaping diagnostics and therapy. A new AI-driven system from Kindai University enhances classification of facial pigmented lesions, while University of...

Pharma companies face notable hurdles as INmune Bio’s Alzheimer’s disease program missed key Phase 2 endpoints despite subgroup benefits, and Pfizer terminated one of two CD47 drug trials from its...

New research reveals critical roles for microbiota and environmental factors in human and ecological health. A mouse study demonstrated that human gut bacteria can bioaccumulate “forever...

Recent innovations in genome editing reveal transformative potential. Researchers introduced a near-infrared-activated chemically induced CRISPR system enabling precise spatiotemporal control of...

New clinical evidence expands indications for existing classes of drugs. A retrospective cohort study published in BMC Cancer suggests sodium-glucose cotransporter-2 inhibitors (SGLT2i), typically...

The biotech sector reflects mixed trends: Sage Therapeutics plans massive layoffs following its acquisition by Supernus Pharmaceuticals amid pipeline challenges. Major venture capital disputes...

AbbVie has agreed to acquire Capstan Therapeutics in a deal valued up to $2.1 billion, advancing the pharma giant’s in vivo CAR-T therapy ambitions. Capstan’s technology enables direct engineering...

Moderna’s seasonal influenza vaccine candidate, mRNA-1010, demonstrated a 26.6% relative vaccine efficacy over a licensed standard-dose seasonal influenza vaccine in adults aged 50 and older...

Sage Therapeutics, soon to be acquired by Supernus Pharmaceuticals, plans to lay off approximately 338 employees, representing the vast majority of its workforce. This decision follows Supernus’s...

Researchers at the University of Sharjah have developed novel artificial intelligence models capable of early-stage pancreatic cancer detection as well as disease prognosis prediction. Given...

Researchers have engineered a chemically induced CRISPR system activated by near-infrared light, enabling precise spatiotemporal genome editing control. This platform expands upon the specificity...

At the 41st Annual Meeting of the European Society of Human Reproduction and Embryology, investigators revealed associations between altered gut microbiota and amino acid metabolism with increased...

A white paper by Tufts Center for the Study of Drug Development, commissioned by Thermo Fisher Scientific, highlights that integrated contract development and manufacturing organization (CDMO) and...